March 11, 2010

Eli Lilly to acquire Pfizer animal health parts

The animal health division of drugmaker Eli Lilly will acquire the rights to a portfolio of Pfizer products in Europe, including vaccines and feed additives.

Pfizer Animal Health has welcomed the signing of an agreement between Pfizer and Elanco, the animal health business unit of Eli Lilly and Company, under which Elanco will acquire European rights to a portfolio of certain Pfizer Animal Health and legacy Fort Dodge Animal Health products.
 

The products - including vaccines, parasiticides and feed additives - have been marketed by Pfizer and Wyeth.
 

As part of a deal, Elanco will take over the manufacturing facility in Sligo, Ireland, which is currently used in the production of animal vaccines.

 
Elanco President Jeff Simmons said in a statement that the deal will allow the company to expand in Europe.

Meanwhile, the European Commission asked Pfizer Inc. to divest some of its assets after it bought drug and health company Wyeth for US$68 billion last year.